227 related articles for article (PubMed ID: 15078928)
1. The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.
Basu A; Beyene A; Meyer K; Ray R
J Virol; 2004 May; 78(9):4478-86. PubMed ID: 15078928
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.
Meyer K; Beyene A; Bowlin TL; Basu A; Ray R
J Virol; 2004 Dec; 78(23):12838-47. PubMed ID: 15542636
[TBL] [Abstract][Full Text] [Related]
3. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
4. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
Lagging LM; Meyer K; Owens RJ; Ray R
J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633
[TBL] [Abstract][Full Text] [Related]
5. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.
Mazumdar B; Banerjee A; Meyer K; Ray R
Hepatology; 2011 Oct; 54(4):1149-56. PubMed ID: 21735466
[TBL] [Abstract][Full Text] [Related]
7. Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.
Basu A; Kanda T; Beyene A; Saito K; Meyer K; Ray R
J Virol; 2007 Apr; 81(8):3933-41. PubMed ID: 17287282
[TBL] [Abstract][Full Text] [Related]
8. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
9. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
[TBL] [Abstract][Full Text] [Related]
10. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.
Meyer K; Basu A; Przysiecki CT; Lagging LM; Di Bisceglie AM; Conley AJ; Ray R
J Virol; 2002 Mar; 76(5):2150-8. PubMed ID: 11836392
[TBL] [Abstract][Full Text] [Related]
12. Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins.
Koutsoudakis G; Dragun J; Pérez-Del-Pulgar S; Coto-Llerena M; Mensa L; Crespo G; González P; Navasa M; Forns X
PLoS One; 2012; 7(12):e52651. PubMed ID: 23300734
[TBL] [Abstract][Full Text] [Related]
13. Targeting of a heterodimeric membrane protein complex to the Golgi: rubella virus E2 glycoprotein contains a transmembrane Golgi retention signal.
Hobman TC; Woodward L; Farquhar MG
Mol Biol Cell; 1995 Jan; 6(1):7-20. PubMed ID: 7749196
[TBL] [Abstract][Full Text] [Related]
14. Cell fusion activity of hepatitis C virus envelope proteins.
Takikawa S; Ishii K; Aizaki H; Suzuki T; Asakura H; Matsuura Y; Miyamura T
J Virol; 2000 Jun; 74(11):5066-74. PubMed ID: 10799580
[TBL] [Abstract][Full Text] [Related]
15. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
[TBL] [Abstract][Full Text] [Related]
16. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2.
Albecka A; Montserret R; Krey T; Tarr AW; Diesis E; Ball JK; Descamps V; Duverlie G; Rey F; Penin F; Dubuisson J
J Virol; 2011 Feb; 85(4):1777-92. PubMed ID: 21147916
[TBL] [Abstract][Full Text] [Related]
17. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
Prentoe J; Jensen TB; Meuleman P; Serre SB; Scheel TK; Leroux-Roels G; Gottwein JM; Bukh J
J Virol; 2011 Mar; 85(5):2224-34. PubMed ID: 21123377
[TBL] [Abstract][Full Text] [Related]
18. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.
Hanika A; Larisch B; Steinmann E; Schwegmann-Weßels C; Herrler G; Zimmer G
J Gen Virol; 2005 May; 86(Pt 5):1455-1465. PubMed ID: 15831958
[TBL] [Abstract][Full Text] [Related]
19. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis.
Codran A; Royer C; Jaeck D; Bastien-Valle M; Baumert TF; Kieny MP; Pereira CA; Martin JP
J Gen Virol; 2006 Sep; 87(Pt 9):2583-2593. PubMed ID: 16894197
[TBL] [Abstract][Full Text] [Related]
20. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins.
Tani H; Komoda Y; Matsuo E; Suzuki K; Hamamoto I; Yamashita T; Moriishi K; Fujiyama K; Kanto T; Hayashi N; Owsianka A; Patel AH; Whitt MA; Matsuura Y
J Virol; 2007 Aug; 81(16):8601-12. PubMed ID: 17553880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]